We conducted RNA-seq analysis using the KEGG pathway approach, revealing that PHF12 potentially modulates the progression of non-small cell lung cancer (NSCLC) through the EGFR/ErbB2 pathway, as illustrated in Fig. 3a. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.